Injective CEO rings Nasdaq bell as Canary’s staked INJ ETF begins trading

Canary's staked Injective ETF, ticker INJC, began trading on Nasdaq on Nov. 5, with Injective's CEO ringing the opening bell. By Friday the fund held $16.12 million in assets across 600,000 shares, with staking yield built into the product. A staked altcoin ETF listing on a major US exchange broadens institutional access to INJ and signals continued expansion of crypto ETF wrappers beyond bitcoin and ether.